Cargando…

Oestrogen is bad for patients with breast cancer?

Detalles Bibliográficos
Autores principales:	Jordan, V Craig, Ariazi, Eric A, Lewis-Wambi, Joan S, Swaby, Ramona R, Cunliffe, Heather E, Riegel, Anna T, Wellstein, Anton
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2230530/ http://dx.doi.org/10.1186/bcr1820

Ejemplares similares

By looking back we can see the way forward: enhancing the gains achieved with antihormone therapy
por: Jordan, V Craig, et al.
Publicado: (2008)

The origins of oestrogen receptor negative breast cancer
por: Allred, D Craig
Publicado: (2007)

Proteomic Analysis of Pathways Involved in Estrogen-Induced Growth and Apoptosis of Breast Cancer Cells
por: Hu, Zhang-Zhi, et al.
Publicado: (2011)

The prognostic significance of tumour–stroma ratio in oestrogen receptor-positive breast cancer
por: Downey, C L, et al.
Publicado: (2014)

The oestrogen paradox: an hypothesis
por: Santen, Richard J
Publicado: (2007)

Assessing individual risk for breast cancer: role of oestrogens and androgens
por: Santen, Richard J
Publicado: (2008)

Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?
por: Lewis-Wambi, Joan S, et al.
Publicado: (2009)

Do classical oestrogen markers predict for clinical response to endocrine therapy?
por: Miller, William R
Publicado: (2007)

321 Impact of CDK4/6 inhibitor-induced cellular senescence on stromal responses to breast cancer
por: Gallanis, Gregory T., et al.
Publicado: (2022)

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
por: Lewis-Wambi, Joan S, et al.
Publicado: (2008)

Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
por: Lewis-Wambi, Joan S., et al.
Publicado: (2018)

Favourable response of serum prostate-specific antigen to conjugated oestrogen in castrate-resistant prostate cancer in Jamaica
por: Condappa, Andrew, et al.
Publicado: (2018)

Possible Association Between Melanoma Arising from Congenital Naevus and Oestrogen or Progesterone Receptor Expression: Clinicopathological Analysis
por: SUMITOMO, Chiho, et al.
Publicado: (2023)

Subpopulations of AIB1 isoform-expressing breast cancer cells enable invasion and metastasis
por: Kiliti, Amber J., et al.
Publicado: (2023)

Targeting oestrogen to kill the cancer but not the patient
por: Lewis, J S, et al.
Publicado: (2004)

Bad to the bones: prescribing of drugs for the prevention and treatment of osteoporosis in patients on chronic glucocorticoids
por: Billups, Sarah J., et al.
Publicado: (2023)

Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation.
por: Pink, J. J., et al.
Publicado: (1996)

The significance of highlighting the oestrogen receptor low category in breast cancer
por: Poon, Ivan K., et al.
Publicado: (2020)

Plasma oestrogens and oestrogen receptors in breast cancer patients.
por: Mason, R. C., et al.
Publicado: (1985)

Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA
por: Hayes, Erin L, et al.
Publicado: (2015)

Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer
por: Provance, Olivia K., et al.
Publicado: (2019)

Not as bad as you think: a comparison of the nutrient content of best price and brand name food products in Switzerland
por: Khalatbari-Soltani, Saman, et al.
Publicado: (2016)

AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer
por: Kiliti, Amber J., et al.
Publicado: (2023)

A new day dawns: women without oestrogen or is a balance best?
por: Jordan, V Craig
Publicado: (2002)

The good, the bad, and the neutral: Vaccine hesitancy mediates the relations of Psychological Capital, the Dark Triad, and the Big Five with vaccination willingness and behaviors
por: Howard, Matt C.
Publicado: (2022)

Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer
por: Jan, Rifat, et al.
Publicado: (2012)

Different methylation of oestrogen receptor DNA in human breast carcinomas with and without oestrogen receptor.
por: Piva, R., et al.
Publicado: (1990)

Retraction Note: Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer
por: Jan, Rifat, et al.
Publicado: (2023)

Molecular classification of selective oestrogen receptor modulators on the basis of gene expression profiles of breast cancer cells expressing oestrogen receptor α
por: Levenson, A S, et al.
Publicado: (2002)

The role of oestrogen and progesterone receptors in breast cancer – immunohistochemical evaluation of oestrogen and progesterone receptor expression in invasive breast cancer in women
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2015)

Circulating tumor cells in breast cancer: A tool whose time has come of age
por: Swaby, Ramona F, et al.
Publicado: (2011)

Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours
por: Skliris, G P, et al.
Publicado: (2006)

Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture
por: Fridriksdottir, Agla J., et al.
Publicado: (2015)

Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation
por: Gellert, Pascal, et al.
Publicado: (2016)

Oestrogens and oestrogen receptors in prostate cancer
por: Kowalska, Karolina, et al.
Publicado: (2016)

Oestrogen receptors in primary breast cancer.
por: Williams, M. R., et al.
Publicado: (1985)

Oestrogen exposure and breast cancer risk
por: Travis, Ruth C, et al.
Publicado: (2003)

Phyto-oestrogens and breast cancer chemoprevention
por: Limer, Jane L, et al.
Publicado: (2004)

The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor.
por: Levenson, A. S., et al.
Publicado: (1998)

The utility of conventional and molecular pathology in managing breast cancer
por: Allred, D Craig
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ss9ghute6pfv34ljfufbl87k93